Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kiniksa Pharmaceuticals International Plc (KNSA)

Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kiniksa Pharmaceuticals International Plc CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 BMU

www.kiniksa.com P: 808-451-3453

Description:

Kiniksa Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa Pharmaceuticals Ltd. is based in Massachusetts, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,506,056
Enterprise Value, $K 1,398,106
Shares Outstanding, K 70,940
Annual Sales, $ 270,260 K
Annual Net Income, $ 14,080 K
Last Quarter Sales, $ 79,860 K
Last Quarter Net Income, $ -17,700 K
EBIT, $ -30,540 K
EBITDA, $ -28,200 K
60-Month Beta 0.38
% of Insider Shareholders 54.57%
% of Institutional Shareholders 53.95%
Float, K 32,228
% Float 45.43%
Short Volume Ratio 0.52

Growth:

1-Year Return 35.15%
3-Year Return 46.41%
5-Year Return 69.57%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 04/23/24
Next Earnings Date 07/23/24 [BMO]
Earnings Per Share ttm -0.43
EPS Growth vs. Prev Qtr -725.00%
EPS Growth vs. Prev Year -38.89%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KNSA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -7.26%
Return-on-Assets % -6.09%
Profit Margin % 5.21%
Debt/Equity 0.00
Price/Sales 5.55
Price/Cash Flow N/A
Price/Book 3.48
Book Value/Share 6.09
Interest Coverage -0.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar